Collaborative Innovative Research Fund

Agency: 
GlaxoSmithKline

GSK is committed to promoting Canadian scientific discovery and innovation. Our mandate is to improve the quality of human life by enabling people to do more, feel better, and live longer. As such, GSK is proud to support medical research in Canada. The GSK CIRF-FRIC initiative is a program that aims to support Investigator Initiated research. To begin the application process interested parties must submit a letter of intent. After reviewing the letters of intent, the GSK CIRF-FRIC review committee will invite selected applicants to submit a full proposal for further evaluation. We welcome your interest in GSK’s exciting research initiative.

Deadline: 
September 2, 2008

Last updated October 20, 2008